With FDA planning to regulate nicotine levels, XXII (holding 200 patents protecting their production/manufaturing methods for making VLN, very low nicotine, tobacco) is well positioned to capitalize on the ~$20b of Big Tobacco market cap lost since July. In July, the FDA publicly announced their ambitions to change tobacco regulation. In addition, the FDA has...
This stock has been in a downtrend since October 2013. It hit bottom in December 2014 with a double bottom price action signal as well as MASSIVE MACD divergence. Once this stock crosses the daily 50 EMA we can see MASSIVE upside potential. Look to take profit (of trail stop loss) to the previous support level of $6.20.
** Note: this is just my view with the...